MYC and familial pancreatic carcinoma: Importantly, several studies demonstrate that c-Myc promotes PD-L1 expression in a variety of tumor types [104,105,106,107,108,109], and anti-PD-L1 and the c-Myc inhibitor JQ1 cause synergistic inhibition of pancreatic cancer xenografts [110].